Microcaps, founded in 2019, is pioneering a Breakthrough technology that naturally encapsulates ingredients and fragrances. Their technology promises enhanced protection and a distinctive visual and sensory experience, catering primarily to the fine fragrance, cosmetics, nutrition, and pharma sectors.
Operating out of Switzerland, this innovative biotechnology firm leverages its patented solution to offer companies improved performance, new product claims, enhanced shelf appeal, and increased revenue potential. The encapsulation process harnesses alginate-beads to deliver visually appealing products while ensuring ingredient integrity.
In its latest funding round, the company secured a Fr.9.30M Series A investment on 05 June 2024. Key investors included Helvetica Capital AG, ETH Zurich Foundation, and Zürcher Kantonal Bank. These strategic partnerships reinforce Microcaps’ promising position in the Biotechnology and Information Technology industries.